# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-009370
Filing Date
2022-04-07
Accepted
2022-04-07 17:08:30
Documents
70
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1692302
2 |  | ex4-1.htm | EX-4.1 | 38075
3 |  | ex21-1.htm | EX-21.1 | 3448
4 |  | ex31-1.htm | EX-31.1 | 20113
5 |  | ex31-2.htm | EX-32.1 | 19867
6 |  | ex32-1.htm | EX-31.2 | 10457
7 |  | ex99-1.htm | EX-99.1 | 38524
8 |  | ex99-2.htm | EX-99.2 | 35658
9 |  | ex99-3.htm | EX-99.3 | 17390
10 |  | form10-k_001.jpg | GRAPHIC | 22902
11 |  | form10-k_002.jpg | GRAPHIC | 12069
12 |  | form10-k_003.jpg | GRAPHIC | 20425
13 |  | form10-k_004.jpg | GRAPHIC | 17323
| Complete submission text file | 0001493152-22-009370.txt |  | 6299746

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL SCHEMA FILE | ptix-20211231.xsd | EX-101.SCH | 43846
15 | XBRL CALCULATION FILE | ptix-20211231_cal.xml | EX-101.CAL | 48500
16 | XBRL DEFINITION FILE | ptix-20211231_def.xml | EX-101.DEF | 210984
17 | XBRL LABEL FILE | ptix-20211231_lab.xml | EX-101.LAB | 387753
18 | XBRL PRESENTATION FILE | ptix-20211231_pre.xml | EX-101.PRE | 294439
64 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 687108

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12555 | Film No.: 22814608
SIC: 7389 Services-Business Services, NEC